Oramed Pharmaceuticals Inc.ORMPNASDAQ
LOADING
|||
Cash Flow Performance
Trending higher.
Left:
||||
Free cash flow yield
Latest
-8.53%
↑ 13% above average
Average (9y)
-9.78%
Historical baseline
Range
High:5.10%
Low:-22.36%
CAGR
+0.5%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | -8.53% | +24.7% |
| 2023 | -11.33% | -82.0% |
| 2022 | -6.22% | -61.8% |
| 2021 | -3.85% | +78.0% |
| 2020 | -17.47% | +21.8% |
| 2019 | -22.36% | -12.3% |
| 2018 | -19.90% | -292.5% |
| 2017 | -5.07% | -199.3% |
| 2016 | 5.10% | +162.7% |
| 2015 | -8.14% | - |